Morphisec Announces $12 Million in Series B Funding

Morphisec today announced it has raised $12 million in Series B funding. The round features new investor Orange Digital Ventures, as well as existing Morphisec investors Jerusalem Venture Partners, GE (NYSE: GE) and Deutsche Telekom (XETRA: DTE). Additional investors in Morphisec include La Maison, Portage Partners, OurCrowd, Kodem Growth Partners and Evolution Equity Partners.

Morphisec offers a new level of innovation to customers using its Endpoint Threat Prevention product, which delivers protection against advanced cyber attacks. The company’s patented Moving Target Defense technology works to prevent threats including APTs, zero-days, ransomware, evasive fileless attacks and web-borne exploits.

According to the company, Morphisec has achieved more than 1,000% growth in 2017, with its technology deployed by hundreds of thousands of endpoints. The company was recognized in 2017 by SE Labs with a 100 percent efficacy performance rate against every attack (evasive malware and exploits) detonated in the lab.